International Federation of Gynecology and Obstetrics

Professor Dr. Aisha Siddiqa, MBBS, FCPS, MSc (University of Glasgow), FRCOG (UK-Hon) is a distinguished obstetrician and gynecologist from Pakistan with more than three decades of experience in clinical practice, medical education, and advocacy for women’s health. She currently serves as a Trustee representing the Asia–Oceania region at the International Federation of Gynecology and Obstetrics (FIGO).

What happens when two life-changing health events – cancer and pregnancy – intersect? This webinar explores the complex intersection of cancer and pregnancy, focusing on clinical care, fertility and survivorship. It will cover the diagnosis and management of cancer during pregnancy, fertility preservation options for patients undergoing treatment and considerations for pregnancy after cancer.

As FIGO Cape Town 2025 draws near, we sat down with Congress Organising Committee (COC) Chair, Professor Paul Fogarty, for an exclusive look into what delegates can expect from this year’s landmark gathering. With a robust scientific programme, hands-on learning opportunities and powerful moments of connection, this is more than a Congress - It’s a catalytic event for global progress in women’s health and rights.

The FIGO Fertility Passport, is a new comprehensive documentation tool designed to transform how patients and healthcare providers navigate fertility investigations and treatments worldwide. Developed by the FIGO Committee on Reproductive Endocrinology and Infertility, the passport addresses a critical gap in fertility care where patients often repeat costly investigations and face treatment delays when moving between clinics or healthcare systems.

Date: Thursday 11 September 2025 Time: 15:00-16:30 UTC Description: This regional expert-led webinar will explore the complex relationship between menopause, hormonal changes and cardiovascular health in women, with a special focus on Latin American contexts. As cardiovascular disease remains a leading cause of death in women, understanding how hormone replacement therapy (HRT) and lipid metabolism influence risk is essential for timely, evidence-based care.

Date: Thursday 21 August 2025 Time: 13:00-14:30 UTC Description: Healthcare workers providing life-saving abortion care often face attacks, intimidation and criminalisation simply for doing their jobs. Hostile environments persist even in countries with provision for legal abortion, creating a chilling, silencing and stigmatising effect on those defending access to abortion services.

Date: Thursday 31 July 2025 Time: 16:00-17:30 UTC Description: Emerging FemTech innovations are reshaping global women’s health by addressing critical gaps in maternal care. In this FIGO regional webinar, leading experts will explore how artificial intelligence (AI)-driven technologies, advanced medical devices and digital tools are being adapted to meet the unmet needs of those experiencing pregnancy and childbirth.

FIGO and the Chien-Tien Hsu Research Foundation have once again partnered to offer outstanding early-career professionals in gynaecologic oncology a transformative opportunity to attend the FIGO World Congress 2025 and gain hands-on experience through clinical and research training at a leading gynaecologic oncology centre in Cape Town, South Africa. We are proud to announce the recipients of the 2025 FIGO and Chien-Tien Hsu Fellowship in Gynaecologic Oncology: Dr Pedro H.

As part of its evolving education offering, FIGO is delighted to launch its first capacity strengthening online course: Gender Data for Healthcare Professional Associations. Developed through the FIGO LDI:REACH programme, the course has been specifically designed for FIGO members and focuses on utilising gender-disaggregated data to identify and address gender inequities within member societies, leading to improved outcomes for both clinicians and patients.

Date: Thursday 10 July 2025 Time: 14:00-15:30 UTC Description: Uterine fibroids are one of the most common yet overlooked challenges in women's health, affecting up to 70% of women by the time they reach menopause. Though generally classified as benign, fibroids can lead to serious health issues including infertility, miscarriage, early labour, postpartum haemorrhage and chronic anaemia caused by heavy menstrual bleeding.